JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266562

Human BZW1 (Protein Orf) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

BZW1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and Insertion of the selection cassette in exon 3. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

BZAP45, BZW1_HUMAN, Basic leucine zipper and W2 domain-containing protein 1, KIAA0005, Nbla10236, Protein Orf, basic leucine-zipper protein BZAP45, putative protein product of Nbla10236

2 Images
Sanger Sequencing - Human BZW1 (Protein Orf) knockout HEK-293T cell line (AB266562)
  • Sanger seq

Unknown

Sanger Sequencing - Human BZW1 (Protein Orf) knockout HEK-293T cell line (AB266562)

Allele-1 : Insertion of the selection cassette in exon3

Sanger Sequencing - Human BZW1 (Protein Orf) knockout HEK-293T cell line (AB266562)
  • Sanger seq

Unknown

Sanger Sequencing - Human BZW1 (Protein Orf) knockout HEK-293T cell line (AB266562)

Allele-2 : 1 bp insertion in exon 3.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and Insertion of the selection cassette in exon 3

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266562-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266562-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266562 Human BZW1 (Protein Orf) knockout HEK-293T cell line", "number":"AB266562-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266562-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266562 Human BZW1 (Protein Orf) knockout HEK-293T cell line", "number":"AB266562-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266562-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266562-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266562 Human BZW1 (Protein Orf) knockout HEK-293T cell line", "number":"AB266562-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266562-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266562 Human BZW1 (Protein Orf) knockout HEK-293T cell line", "number":"AB266562-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
BZW1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

BZW1 also known as Protein Orf is a member of the basic leucine zipper (bZIP) family of proteins. The mass of BZW1 is approximately 42 kDa. It is mainly expressed in the nucleus of cells. BZW1 plays a role in the regulation of transcription and translation processes. This regulation occurs through its interaction with specific sequences on the DNA and RNA contributing to the modification of gene expression.
Biological function summary

BZW1 influences cell growth and proliferation by engaging in the regulation of gene transcription. It can interact with other proteins to form complexes that modulate these processes. BZW1 adjusts protein synthesis rates by acting at the level of translational control affecting cellular responses to different growth conditions. Its function supports overall cellular homeostasis by ensuring proteins are produced as needed.

Pathways

BZW1 is integral to both the mTOR and eIF2 signaling pathways which are critical in regulating protein synthesis and stress responses. It is related to other proteins like mTOR and eIF2α within these pathways and its activity can influence how cells respond to nutrient availability and environmental changes.

Alterations in BZW1 expression have associations with cancer and neurodegenerative diseases. In cancer dysregulation of BZW1 can affect the cell cycle by impacting the proteins involved like p53 thereby promoting uncontrolled cell proliferation. In neurodegenerative diseases changes in its function can disrupt protein homeostasis leading to the accumulation of proteins that contribute to disease progression and pathways involving proteins like α-synuclein.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com